Source comparison
BPC-157 for CrossFit Recovery Research: Comparison
Chronic Tendinopathy (Achilles, patellar, rotator cuff) Strong. Multiple animal studies show 60–80% faster healing vs controls 200–300 mcg daily, local injection near injury site, 28–42 day cycle Noticeable pain reduction in 10–14 days; structural improvement
This comparison does not assign a generated winner or score.
- Chronic Tendinopathy (Achilles, patellar, rotator cuff)
- Strong. Multiple animal studies show 60–80% faster healing vs controls
- 200–300 mcg daily, local injection near injury site, 28–42 day cycle
- Noticeable pain reduction in 10–14 days; structural improvement visible on ultrasound at 4–6 weeks
- No large human RCTs; dosing extrapolated from rat studies using allometric scaling
- Best-supported application. Research mechanisms (angiogenesis + collagen synthesis) directly address tendon pathology.
- Acute Ligament Sprains (ankle, knee MCL/LCL)
- Moderate. Animal models show 50–70% faster healing; limited human data
- 200–400 mcg daily, local injection, 14–21 day cycle starting within 48 hours of injury
- Stability improvement within 7–10 days; full healing 2–3 weeks faster than untreated
- Acute injuries heal relatively fast naturally; benefit magnitude less dramatic than chronic injuries
- Promising but less critical than for chronic conditions. Main benefit appears to be reducing long-term instability.
- Muscle Strains (hamstring, quad, calf)
- Weak-to-Moderate. Shows faster inflammation resolution but modest timeline improvement
- 250–400 mcg daily, systemic injection acceptable, 14–21 day cycle
- Healing 20–30% faster than natural recovery; primary benefit is reduced scar tissue formation
- Muscle heals faster than tendon naturally; practical benefit is incremental rather than transformative
- Use only for severe (Grade 2–3) tears where scar tissue and ROM loss are concerns. Minor strains don't justify the intervention.
- Bone Stress Fractures
- Limited. Two small animal studies show 35–45% faster callus formation; no human data
- 300–500 mcg daily, systemic injection, 42–56 day cycle
- Radiographic healing approximately 10–14 days faster than untreated
- Minimal research base; bone healing timeline is inherently long; unclear if peptide affects final bone density
- Intriguing but speculative. Consider only for recurrent stress fractures where healing has stalled.
- Neurological Injuries (nerve compression, neuropathy)
- Very Limited. One study on sciatic nerve crush injury showed 30% faster recovery; mechanism unclear
- Not established. Research used 10 mcg/kg in rats; human equivalent unclear
- Unknown
- Single study; mechanism doesn't align with BPC-157's known pathways; may be indirect effect via inflammation reduction
- Insufficient evidence to recommend. If considering, treat as experimental and monitor closely.